Article Information
History
- September 7, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Janine M. Joseph, MS, MBA1,*,
- Jens Hillengass, MD, PhD2,
- Li Tang, PhD1,
- Alexander M. Lesokhin, MD3,
- Ola Landgren, MD, PhD4,
- Saad Z. Usmani, MD3,
- Kirsten B. Moysich, PhD1,
- Susan E. McCann, PhD1,† and
- Urvi A. Shah, MD3,*
- 1Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
- 2Myeloma Section, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
- 3Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- 4Myeloma Service, Department of Medicine, Sylvester Comprehensive Cancer Center at the University of Miami, Miami, FL, USA
- ↵*Corresponding Authors: Janine M. Joseph, MS, MBA, Pre-Doctoral Trainee, Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Elm & Carlton Streets, Buffalo, New York 14263, Email: janine.joseph{at}roswellpark.org, Office: 716-845-8937, Fax: 716-845-8487 Urvi A. Shah, MD, Myeloma Service, Department of Medicine, Assistant Attending, Memorial Sloan Kettering Cancer Center, 530 East 74th Street, New York, New York 10021, Email: shahu{at}mskcc.org, Office: 646-608-3713, Fax: 929-321-7405